Trial Profile
A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Acronyms TCZALS-001
- 01 Sep 2021 Results published in the Muscle and Nerve
- 25 Jul 2018 Status changed from active, no longer recruiting to completed.
- 09 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jul 2018.